Internal Medicine, Rheumatology · Spokane, WA
NPI
1275981706
Since 2016
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
105 W 8th Ave Ste 7010
Spokane, WA, 99204
Phone (509) 747-1144
Groups this clinician bills Medicare through
Medicare paid, 2024
$241K
13,435 services
Medicare patients, 2024
312
Average age 70
Drug cost, 2024
$916K
2,121 prescriptions
Company payments, 2025
$1,309
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Barbara Jacobs was code 99214 (office e&m - established), 391 times for 230 patients. In total Barbara Jacobs billed 13,435 services in 40 codes, and Medicare paid $241K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-10-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 391 | 230 | $87.91 | $34K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 302 | 229 | $12.39 | $3,742 |
| 99215 Office E&M - Established | Office | 130 | 99 | $124.34 | $16K |
| 96365 Intravenous Infusion, Hydration | Office | 66 | 26 | $45.62 | $3,011 |
| J3489 Injection, zoledronic acid, 1 mg | Office | 65 | 13 | $4.34 | $282 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 56 | 12 | $0.72 | $40.47 |
| 96415 Chemotherapy Administration | Office | 37 | 12 | $22.04 | $816 |
| 99205 Office E&M - New | Office | 35 | 35 | $141.56 | $4,955 |
| 36415 Venipuncture Blood Collection | Office | 34 | 21 | $8.29 | $282 |
| 96413 Chemotherapy Administration | Office | 24 | 12 | $103.63 | $2,487 |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 15 | 13 | $22.77 | $341 |
| 20610 Joint Injection | Office | 12 | 11 | $55.67 | $668 |
By year: 2022 $494K for 22,431 services; 2023 $472K for 23,897 services; 2024 $241K for 13,435 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 34 | 21 | $8.29 | $282 |
Medicare prescription drug claims, 2024
In 2024, the drug Barbara Jacobs prescribed most often to Medicare patients was Hydroxychloroquine Sulfate, with 416 prescriptions and refills. In total Barbara Jacobs wrote 2,121 Medicare prescriptions that cost $916K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate Generic | 416 | 1,066 | 154 | $21K |
| Methotrexate Methotrexate Sodium | 415 | 970 | 154 | $13K |
| Prednisone Generic | 280 | 416 | 104 | $1,818 |
| Leflunomide Generic | 165 | 385 | 63 | $11K |
| Folic Acid Generic | 81 | 244 | 31 | $939 |
| Mycophenolate Mofetil Generic | 58 | 84 | Under 11 | $5,763 |
| Allopurinol Generic | 55 | 114 | 20 | $453 |
| Methylprednisolone Generic | 52 | 67 | 36 | $711 |
| Sulfasalazine Dr Sulfasalazine | 48 | 65 | Under 11 | $1,442 |
| Alendronate Sodium Generic | 47 | 116 | 15 | $331 |
| Sulfasalazine Generic | 40 | 88 | 15 | $1,373 |
| Omeprazole Generic | 37 | 61 | 15 | $403 |
| Celecoxib Generic | 34 | 67 | 12 | $871 |
| Sodium Chloride 0.9 % Sodium Chloride | 31 | 31 | Under 11 | $106 |
| Colchicine Generic | 30 | 60 | 16 | $1,000 |
Brand drugs: - claims; generic drugs: 1,883 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Barbara Jacobs $1,309 ($1,309 in general payments such as food, travel and fees) from 13 companies. The largest payer was Amgen Inc. with $516.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 35 | $516 |
| Insulet Corporation PODD | 8 | $197 |
| AstraZeneca Pharmaceuticals LP AZN | 7 | $169 |
| GlaxoSmithKline, LLC. GSK | 5 | $94.54 |
| Lilly USA, LLC LLY | 4 | $91.95 |
| Abbvie Inc. ABBV | 3 | $75.64 |
| Dexcom, Inc. DXCM | 1 | $35.34 |
| Pfizer Inc. PFE | 2 | $34.16 |
| E.R. Squibb & Sons, L.L.C. BMY | 1 | $24.74 |
| Novartis Pharmaceuticals Corporation NVS | 1 | $21.44 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.